Zoetis (ZTS) Total Debt Growth (3y) (2015 - 2026)
Zoetis (ZTS) Total Debt Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | -2.21% |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | -7.03% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 11.29% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 63.29% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -7.76% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | -14.15% |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 50.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.29% |
| Dec 31, 2025 | 11.32% |
| Sep 30, 2025 | 10.69% |
| Jun 30, 2025 | 8.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.11% |
| Sep 30, 2024 | -0.09% |
| Jun 30, 2024 | -3.00% |
| Mar 31, 2024 | -2.87% |
| Dec 31, 2023 | -3.01% |
| Sep 30, 2023 | -5.22% |
| Jun 30, 2023 | -5.19% |
| Mar 31, 2023 | 0.51% |
| Dec 31, 2022 | 3.29% |
| Sep 30, 2022 | -6.84% |
| Jun 30, 2022 | -6.77% |
| Mar 31, 2022 | 0.69% |
| Dec 31, 2021 | 0.76% |
| Sep 30, 2021 | 0.78% |
| Jun 30, 2021 | 13.22% |